Drug Trial Radar · NCT01034306
Oral CF101 Tablets Treatment in Patients With Rheumatoid Arthritis
Last checked: Nov 20, 2026Latest source record: May 24, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
79
Actual
Start
Oct 2010
Primary completion
Dec 2013
Study completion Dec 2013
Sponsor
- Lead sponsor
- Can-Fite BioPharmaIndustry
- Sponsor type
- Industry
- First posted
- Dec 17, 2009
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial will test the hypothesis that the administration of CF101, a novel anti-inflammatory agent, to patients with rheumatoid arthritis and high A3AR expression at baseline will relieve signs and symptoms of the disease.
Conditions
- Rheumatoid Arthritis
Interventions
CF101Drug
orally q12h
Placebo controlDrug
orally q12 hours
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Subjects Achieving an American College of Rheumatology 20 (ACR20) Response (20% Improvement)Time frame: 12 weeks
Locations
5 sites in 2 countries. Site status is shown where the registry gives one.
Multiprofile Hospital for Active Treatment
Sofia, Bulgaria
Diagnostic Consultative Center Sofia
Sofia, Bulgaria
Military Medical Academy
Sofia, Bulgaria
UMHAT "Sveti Ivan Rilski", Rheumatoloty Clinic
Sofia, Bulgaria
Barzilai Medical Center
Ashkelon, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.